# This Study Evaluates the Superiority of Daily Self-pH Monitorization of Lit-control®pH Meter Compared to the Monitorization of Reactive Strips (Standard of Care).

> **NCT03539926** · NA · UNKNOWN · sponsor: **Devicare S.L.** · enrollment: 60 (estimated)

## Conditions studied

- Cystinuria

## Interventions

- **DEVICE:** Lit-control®pH Meter
- **DIAGNOSTIC_TEST:** Reactive strips

## Key facts

- **NCT ID:** NCT03539926
- **Lead sponsor:** Devicare S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-09
- **Primary completion:** 2018-12
- **Final completion:** 2019-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03539926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03539926, "This Study Evaluates the Superiority of Daily Self-pH Monitorization of Lit-control®pH Meter Compared to the Monitorization of Reactive Strips (Standard of Care).". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03539926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*